The Estée Lauder Companies Announces BEAUTY&YOU India 2025 Winners, Celebrating the Next Generation of Beauty Entrepreneurs
8.10.2025 21:24:00 CEST | Business Wire | Press Release
The Estée Lauder Companies Inc. (NYSE: EL) announced yesterday the winners of BEAUTY&YOU India 2025. This year’s program, supported by the Government of India’s Startup India and launch partner Nykaa, highlighted the emerging talent reimagining the future of beauty in India.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251008512593/en/
From L to R: Jaspreet Singh Gulati, Founder & Director, HiTech Formulations; Aparna Saxena, Founder & CEO, Antinorm; Stéphane de La Faverie, President & CEO, The Estée Lauder Companies; Harsha Soundararajan, Founder, Mimiq; Khanak Gupta, Co-Founder & CEO, Sohrai Beauty; and Rohan Vaziralli, General Manager, The Estée Lauder Companies India.
Stéphane de La Faverie, President and CEO, The Estée Lauder Companies said: “When we launched BEAUTY&YOU, our vision was simple yet powerful — to discover and support visionary entrepreneurs transforming India’s beauty landscape. This year’s winners reflect the incredible creativity, ambition, and innovation shaping one of the world’s most dynamic markets. The Estée Lauder Companies is proud to champion these bold new entrepreneurs who are redefining the future of beauty in India and beyond.”
Since its launch in 2022, the company’s BEAUTY&YOU India program has grown into one of the most recognized platforms for beauty entrepreneurship in India. Over the past four application cycles, it has attracted nearly 2,500 applications from 150+ cities across India and around the world, with the majority from women entrepreneurs.
The 2025 winners, named across four categories, were selected for their bold ideas and innovative products that reflect the dynamism of India’s beauty ecosystem—from climate-tailored products to breakthrough encapsulation technology and inclusive makeup. Each will receive funding, along with mentorship from global experts, national visibility through Startup India, and brand-building and distribution support from Nykaa.
2025 BEAUTY&YOU India Winners
- GROW: Best in-market beauty brand
Antinorm, Aparna Saxena, Founder & CEO: For high-performance, climate-tailored, and multitasking products that replace complex routines for busy working women.
- IMAGINE: Best pre-launch beauty concept
Mimiq, Harsha Soundararajan, Founder: For inclusive, high-performance, and long-lasting complexion products for people with visible skin differences, such as vitiligo.
- BREAKTHROUGH: Best in innovation
Hitech Formulations, Jaspreet Singh Gulati, Founder & Director: For breakthrough encapsulation technology that delivers formulations for pigmentation, anti-aging, and antioxidant-driven skin care.
- VISIONARY WOMEN’S AWARD: Recognizing a trailblazing woman entrepreneur in partnership with Startup India
Sohrai, Khanak Gupta, Co-Founder: For delivering high-performing products using an indigenous ingredient, Mahua, that is sourced through local partnerships that create economic opportunities for tribal communities and women.
The 2025 program debuted the BEAUTY&YOU Visionary Women’s Award, presented by The Estée Lauder Companies (ELC) and Startup India. The award builds upon a first-of-its-kind partnership between ELC and Startup India, formalized through a Memorandum of Understanding with the Government of India’s Department for Promotion of Industry and Internal Trade (DPIIT), reflecting a shared commitment to supporting Indian entrepreneurs and women-led startups.
Nadine Graf, President of EMEA, UK & Ireland, and Emerging Markets at The Estée Lauder Companies, said: “The winners of BEAUTY&YOU India 2025 reflect the entrepreneurial spirit at the heart of The Estée Lauder Companies. India continues to inspire us—not only as a dynamic and fast-growing beauty market, but as a source of creativity and bold ideas. Every journey begins with a vision and a dream, and this program is about empowering founders to turn those into reality. I am especially proud of the new Visionary Women’s Award, which celebrates the ambition, ingenuity, and leadership of women founders.”
Shri Sanjiv Singh, Joint Secretary, Department for Promotion of Industry and Internal Trade, added: “Our partnership with Estée Lauder for BEAUTY&YOU India reflects a shared commitment to strengthening India’s startup ecosystem and fostering innovation across sectors. This year’s introduction of the Visionary Women’s Award in collaboration with Startup India is particularly meaningful, celebrating the women whose ideas and leadership continue to redefine entrepreneurship. My warm congratulations to all the winners as they carry Bharat’s spirit of innovation to the world.”
The 2025 finalists were evaluated by an esteemed jury of beauty and business leaders including Akhil Shrivastava, Executive Vice President & Chief Financial Officer, The Estée Lauder Companies; Rohan Vaziralli, General Manager, The Estée Lauder Companies, India; Nivruti Rai, CEO, Invest India; Katrina Kaif, Actor and Co-Founder, Kay Beauty; and Anchit Nayar, Executive Director & CEO, Nykaa Beauty. The final event featured The Estée Lauder Companies’ Stéphane de La Faverie, President & CEO; William P. Lauder, Chair, Board of Directors; and Nadine Graf, President, EMEA, UK&I, and Emerging Markets; as well as Nykaa’s Falguni Nayar, Chairperson, MD& CEO.
Rohan Vaziralli, General Manager India, The Estée Lauder Companies, India said: “For me, the power of BEAUTY&YOU lies in unlocking possibilities – for entrepreneurs, consumers, and the broader beauty ecosystem – as we continue to build and imagine new futures together. The founders we celebrated tonight are scaling with ambition, setting new standards for Indian beauty on the world stage, and proving that India will be central to defining beauty’s next chapter.”
Anchit Nayar, Executive Director & CEO of Nykaa Beauty said: “As India’s leading beauty destination, Nykaa has been at the forefront of building the country’s beauty ecosystem—from discovery and consumer insights to digital storytelling and omnichannel retail. Through our partnership with The Estée Lauder Companies on BEAUTY&YOU India, we’re extending that ecosystem to nurture early-stage founders with the tools, visibility, and guidance they need to scale. This initiative reflects our shared commitment to empowering the next generation of entrepreneurs who will define the future of Indian beauty, both at home and on the global stage.”
BEAUTY&YOU India celebrates the creativity and vision of founders who are reshaping what beauty can mean for consumers in India and beyond. Alumni have gone on to launch new products, secure venture capital, build partnerships with leading retailers, and gain national attention on platforms like Shark Tank India, reinforcing the program’s role as a driver of industry transformation.
For more information, visit www.beautyandyouawards.com.
About BEAUTY&YOU India
Created by The Estée Lauder Companies’ New Incubation Ventures, BEAUTY&YOU India aims to discover, propel, and support the next generation of India-focused beauty entrepreneurs. Launched in 2022, the program offers financial support, mentorship, and strategic guidance to entrepreneurs shaping the future of beauty in India, helping them achieve scale and global relevance.
About The Estée Lauder Companies Inc.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251008512593/en/
Contacts
Media Relations:
Brendan Riley
briley@estee.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom